{
  "docId": "019de070-c58c-706c-98f1-9eec26811648",
  "docSlug": "2a1e5b2d3a1cb25fe50abb3e75ae9bdf",
  "documentTitle": "Alkermes | Investor Day Presentation Deck | 144 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 132,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c58c-706c-98f1-9eec26811648/32",
  "deckHref": "/decks/019de070-c58c-706c-98f1-9eec26811648",
  "deckJsonHref": "/decks/019de070-c58c-706c-98f1-9eec26811648.json",
  "deckAnchorHref": "/decks/019de070-c58c-706c-98f1-9eec26811648#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.046,
        "w": 0.04,
        "x": 0.258,
        "y": 0.305
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "iconography",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3be26e55-c629-49f9-9e1a-87e6ded535ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.33,
        "x": 0.115,
        "y": 0.625
      },
      "kind": "list",
      "text": "Monetization of non-core assets; Strategic collaboration for nemvaleukin and other oncology assets",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bb36706-ecd9-429f-95ba-6b42c6097d30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.48,
        "y": 0.45
      },
      "kind": "list",
      "text": "Elements of legacy drug delivery/drug manufacturing business; Platforms; Intellectual property; Preclinical and clinical assets outside of strategic portfolio",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3dbfefbe-3ac7-4b77-a159-c8eba1cbac3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.72,
        "y": 0.45
      },
      "kind": "list",
      "text": "Monetization of royalty revenue streams from third-party products; Risk-sharing product development structures",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6051ed5d-7492-42dd-8b8a-703dfa7f1d5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.7,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Value Enhancement Plan Includes Evaluation of Strategic Opportunities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f45ee46-9cc8-43f1-92f6-aa4313c2c450",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}